<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="cmdc202000524-tbl-0001" xml:lang="en" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Summary of activity‐directed synthesis case studies.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col span="1"/>
  <col span="1"/>
  <col span="1"/>
  <col span="1"/>
  <col span="1"/>
  <col span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th valign="top" rowspan="1" colspan="1">
     <p> </p>
    </th>
    <th valign="top" rowspan="1" colspan="1">
     <p>Biological target (assay type)</p>
    </th>
    <th valign="top" rowspan="1" colspan="1">
     <p>Underpinning chemistry</p>
    </th>
    <th valign="top" rowspan="1" colspan="1">
     <p>Medicinal chemistry strategy</p>
    </th>
    <th valign="top" rowspan="1" colspan="1">
     <p>Number of rounds and reactions</p>
    </th>
    <th valign="top" rowspan="1" colspan="1">
     <p>Discoveries</p>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <bold>1</bold> (Figure 
      <xref rid="cmdc202000524-fig-0002" ref-type="fig">2</xref>, 
      <xref rid="cmdc202000524-bib-0009" ref-type="ref">9</xref>)
     </p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Androgen receptor (FRET)</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Metal carbenoid</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Scaffold discovery</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>3 rounds (36, 192 and 108 reactions)</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Agonists and partial agonists with sub‐micromolar activity Scaffolds with no previously annotated AR activity</p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <bold>2</bold> (Figure 
      <xref rid="cmdc202000524-fig-0003" ref-type="fig">3</xref>, 
      <xref rid="cmdc202000524-bib-0011" ref-type="ref">11</xref>)
     </p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Androgen receptor (FRET)</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Metal carbenoid</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Fragment growth</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>3 rounds (192, 86 and 48 reactions)</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Four distinct chemotypes Elaborated fragments with low micromolar (or better) activity</p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <bold>3</bold> (Figure 
      <xref rid="cmdc202000524-fig-0004" ref-type="fig">4</xref>, 
      <xref rid="cmdc202000524-bib-0012" ref-type="ref">12</xref>)
     </p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <italic>S. aureus</italic> (cell‐based bacterial)
     </p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Pd‐catalysed carbonylation</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>SAR expansion</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>1 round (220 reactions)</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Expanded series of antibacterial quinazolinones</p>
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <p>
      <bold>4</bold> (Figure 
      <xref rid="cmdc202000524-fig-0005" ref-type="fig">5</xref>, 
      <xref rid="cmdc202000524-bib-0014" ref-type="ref">14</xref>)
     </p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>p53/
      <italic>h</italic>DM2 PPI (fluorescence anisotropy)
     </p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Metal carbenoid</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Scaffold hopping</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>2 rounds (154 and 192 reactions)</p>
    </td>
    <td valign="top" rowspan="1" colspan="1">
     <p>Experimental scaffold hopping to yield low micromolar PPI inhibitors Ligands for a binding site not evolved to bind small molecules</p>
    </td>
   </tr>
  </tbody>
 </table>
 <permissions>
  <copyright-holder>Wiley‐VCH Verlag GmbH &amp; Co. KGaA</copyright-holder>
 </permissions>
</table-wrap>
